360
Participants
Start Date
July 3, 2025
Primary Completion Date
February 18, 2030
Study Completion Date
February 24, 2030
Docetaxel
Administered via Intravenous (IV) infusion at a specified dose on specified days
Ifinatamab Deruxtecan
Administered via IV infusion at a specified dose on specified days
MK-5684
Administered orally at a specified dose on specified days
Abiraterone
Administered orally at a specified dose on specified days
Enzalutamide
Administered orally at a specified dose on specified days
RECRUITING
Auckland City Hospital ( Site 0831), Auckland
RECRUITING
Macquarie University-MQ Health Clinical Trials Unit ( Site 0801), Macquarie University
RECRUITING
Taipei Veterans General Hospital ( Site 0901), Taipei
RECRUITING
Fondazione IRCCS Istituto Nazionale Dei Tumori ( Site 0431), Milan
RECRUITING
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia ( Site 0432), Brescia
RECRUITING
Hospital Universitario Ramon y Cajal ( Site 0620), Madrid
RECRUITING
Hospital Universitario 12 de Octubre ( Site 0622), Madrid
RECRUITING
Taichung Veterans General Hospital ( Site 0902), Taichung
RECRUITING
NCT ( Site 0528), Heidelberg
RECRUITING
ONCOCENTRO APYS ( Site 0234), Viña del Mar
RECRUITING
Rambam Health Care Campus ( Site 0400), Haifa
RECRUITING
Clinica Universidad Catolica del Maule ( Site 0236), Talca
RECRUITING
Rabin Medical Center ( Site 0402), Petah Tikva
RECRUITING
Sheba Medical Center ( Site 0401), Ramat Gan
RECRUITING
Sourasky Medical Center ( Site 0403), Tel Aviv
RECRUITING
Bradfordhill ( Site 0231), Santiago
RECRUITING
Instituto Alexander Fleming ( Site 0202), Ciudad Autónoma de Buenos Aires
RECRUITING
Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0200), La Rioja
RECRUITING
Liga Norte Riograndense Contra o Câncer ( Site 0271), Natal
RECRUITING
Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0270), Porto Alegre
RECRUITING
Hospital Moinhos de Vento ( Site 0278), Porto Alegre
RECRUITING
Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0263), São José do Rio Preto
RECRUITING
IPITEC ( Site 0275), São Paulo
RECRUITING
IBCC - Instituto Brasileiro de Controle do Câncer ( Site 0269), São Paulo
RECRUITING
Universitaetsklinikum Jena ( Site 0525), Jena
RECRUITING
Fondazione Policlinico Universitario Agostino Gemelli ( Site 0433), Roma
RECRUITING
UMC St. Radboud ( Site 0679), Nijmegen
RECRUITING
Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 0590), Poznan
RECRUITING
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 0586), Warsaw
RECRUITING
Uniwersyteckie Centrum Kliniczne ( Site 0588), Gdansk
RECRUITING
Szpital Wojewódzki im. M.Kopernika Oddział Onk. Klinicznej z Pododdziałem Chemioterapii Jednodniowej ( Site 0587), Koszalin
RECRUITING
Asan Medical Center ( Site 0925), Songpagu
ACTIVE_NOT_RECRUITING
Severance Hospital Yonsei University Health System ( Site 0924), Seoul
RECRUITING
Samsung Medical Center ( Site 0926), Seoul
RECRUITING
Royal Marsden Hospital (Sutton) ( Site 0741), London
Collaborators (1)
Daiichi Sankyo
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY